Posts for BIOMERICA INC ($BMRA)

Showing 1 - 2 of 2 Posts

$BMRA

•

Form 10-Q

•

2025-01-14

Last updated: 4 months ago

Biomerica, Inc. (NASDAQ: BMRA) Q3 2024 Report: Revenue Growth Meets Financial Challenges

Explore Biomerica's Q3 2024 financial report highlighting revenue growth to $1.636M amid liquidity issues and customer concentration risks. Recommendations suggest a cautious hold.

Biomedical Technology Diagnostic Products Gastrointestinal Health Revenue Growth Analysis Liquidity Challenges

Biomerica, Inc. 8-K Report: Key Insights & Stock Details as of Dec 13, 2024

$BMRA

•

Form 8-K

•

2024-12-17

Last updated: 5 months ago

Biomerica, Inc. 8-K Report: Key Insights & Stock Details as of Dec 13, 2024

Explore Biomerica, Inc.'s 8-K filing from December 13, 2024, detailing corporate changes, stock info, and financial context. Stay informed on BMRA's latest updates!

Biomerica Inc NASDAQ BMRA financial reporting 8-K filing XBRL